Plewman Patrick 4

What Happened
Patrick Plewman, SVP for Diagnostic Services at Quest Diagnostics, received 5,682 shares on 2026-03-04 as settlement of a performance stock award (value $1,164,015). To cover tax withholding, 2,827 of those shares were surrendered to the issuer on 2026-03-04 at $204.86 (value $579,139). The remaining 2,855 shares were sold in the open market on 2026-03-05 at $206.21 for $588,730 pursuant to a pre-established Rule 10b5-1 plan. The award is an acquisition (not a cash purchase); the later actions were routine tax withholding and a planned sale.

Key Details

• Award (A): 5,682 shares @ $204.86 on 2026-03-04 — $1,164,015 (F1: performance stock award settlement).
• Tax withholding (F): 2,827 shares @ $204.86 on 2026-03-04 — $579,139 (F2: shares surrendered to issuer to cover taxes).
• Sale (S): 2,855 shares @ $206.21 on 2026-03-05 — $588,730 (F3: sold under a Rule 10b5-1 plan).
• Filing date: Form 4 filed 2026-03-06; filing appears timely.
• Shares owned after transaction: Not specified in the provided filing.

Context
This was primarily a settlement of a performance award, followed by standard tax withholding and a sale under a pre-set 10b5-1 plan. Performance-share settlements and related withholding are common and do not by themselves indicate a change in insider view; sales under 10b5-1 plans are executed according to a pre-arranged schedule.